Samuel Hume @DrSamuelBHume · 30 Aug 2026
This week in medicine 1. Revolution Medicines' daraxonrasib gets FDA-approved! 2. Moderna's personalized cancer vaccine succeeds in a phase 3 trial for melanoma 3. Nektar's Treg-boosting antibody treats eczema in a phase 2 trial 4. Researchers at the Universities of
26 323Views
334Likes
52Reposts
17Replies
7Quotes
125Bookmarks
Is that a lot?
4.55×vs this author's median5 788 views is typical
60Percentile for this authorof 5 recent posts
13.5×vs 10K–100K median1 948 views is typical
43.42%Reachviews ÷ followers
1.56%Engagement rateof viewers reacted